Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POAM: Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery
NCT06287619Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by University Health Network. Started Apr 2025; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06287619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06287619.